Literature DB >> 3332618

Differential accumulation of oocyte nuclear proteins by embryonic nuclei of Xenopus.

C Dreyer1.   

Abstract

Oocyte nuclear proteins of Xenopus are distributed into the cytoplasm of the maturing egg after germinal vesicle breakdown. Later they are found in all cell nuclei of the embryo. At early stages of development, different nuclear proteins behave differently. A class of 'early shifting' antigens is accumulated by pronuclei and cleavage nuclei, whereas others appear to be excluded from the nuclei at early stages but are shifted into the nuclei at blastula or during and after gastrulation. Accumulation of 'late-shifting' nuclear antigens is a gradual process and occurs during a period characteristic of each protein. Multiple artificial pronuclei can be formed after injection of sperm nuclei, erythrocyte nuclei or pure lambda-DNA into unfertilized eggs. The artificial pronuclei accumulate early- but not late-shifting proteins. Early-migrating proteins rapidly accumulate into the germinal vesicle after de novo synthesis in the oocyte, indicating that the efficiency of translocation into nuclei is an intrinsic property of each protein. Artificial extension of the length of the cell cycle before midblastula transition does not lead to accumulation of the late-shifting nuclear antigens investigated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3332618     DOI: 10.1242/dev.101.4.829

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  11 in total

1.  Smicl is required for phosphorylation of RNA polymerase II and affects 3'-end processing of RNA at the midblastula transition in Xenopus.

Authors:  Clara Collart; Joana M Ramis; Thomas A Down; James C Smith
Journal:  Development       Date:  2009-10       Impact factor: 6.868

2.  Immunolocalization of a nuclear protein bound to the sphere organelle during oogenesis and embryogenesis inPleurodeles waltl.

Authors:  Dominique Boucher; Marie-Thérèse Loones; Chandra K Pyne; Françoise Simon; Corinne Abbadie; Jacques Charlemagne; Jean-Claude Lacroix
Journal:  Rouxs Arch Dev Biol       Date:  1991-08

3.  Nuclear accumulation of S-adenosylhomocysteine hydrolase in transcriptionally active cells during development of Xenopus laevis.

Authors:  N Radomski; C Kaufmann; C Dreyer
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

4.  The distribution of nucleoplasmin in early development and organogenesis of Xenopus laevis.

Authors:  D Wedlich; C Dreyer
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

5.  Nuclear size scaling during Xenopus early development contributes to midblastula transition timing.

Authors:  Predrag Jevtić; Daniel L Levy
Journal:  Curr Biol       Date:  2014-12-04       Impact factor: 10.834

6.  Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus.

Authors:  Yasushi Saka; Anja I Hagemann; Olaf Piepenburg; James C Smith
Journal:  Development       Date:  2007-10-24       Impact factor: 6.868

7.  Selective and rapid nuclear translocation of a c-Myc-containing complex after fertilization of Xenopus laevis eggs.

Authors:  J M Lemaitre; S Bocquet; R Buckle; M Mechali
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

8.  Cycling of intracellular pH during cell division of Xenopus embryos is a cytoplasmic activity depending on protein synthesis and phosphorylation.

Authors:  N Grandin; M Charbonneau
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

9.  DNA methyltransferase is actively retained in the cytoplasm during early development.

Authors:  M C Cardoso; H Leonhardt
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

10.  Cytoplasmic retention of Xenopus nuclear factor 7 before the mid blastula transition uses a unique anchoring mechanism involving a retention domain and several phosphorylation sites.

Authors:  X Li; W Shou; M Kloc; B A Reddy; L D Etkin
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.